US FDA Experts Advise Industry On How To Rid Drug Manufacturing Processes Of Nitrosamines
No Uniform Checklist for Performing Risk Assessments
FDA officials say that process and supply chain risks are some of the root causes driving many of the nitrosamine contamination problems in recent months and manufacturers should work to contain and control these risks.
